(Q39828319)

English

Bactericidal activity and killing rate of serum in volunteers receiving teicoplanin alone or in combination with oral or intravenous rifampin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Bactericidal activity and killing rate of serum in volunteers receiving teicoplanin alone or in combination with oral or intravenous rifampin (English)

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

author name string

Van der Auwera P

1

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Klastersky J

2

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

language of work or name

0 references

publication date

1 July 1987

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

31

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

7

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

1002-1005

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

Method of reliable determination of minimal lethal antibiotic concentrations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

22 September 2017

Interaction Between Vancomycin and Rifampin Against Staphylococcus aureus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

22 September 2017

Value of serum tests in combined drug therapy of endocarditis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

22 September 2017

Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

22 September 2017

Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

22 September 2017

Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampin and aminoglycosides against staphylococci and enterococci

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

22 September 2017

Simplified, accurate method for antibiotic assay of clinical specimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

22 September 2017

Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

22 September 2017

Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

22 September 2017

Serum Dilution Test for Bactericidal Activity. II. Standardization and Correlation with Antimicrobial Assays and Susceptibility Tests

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

25 September 2017

Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

17 June 2018

Use of rifampin for the treatment of serious staphylococcal and gram-negative bacillary infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

17 June 2018

Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

17 June 2018

Vancomycin therapy of oxacillin-resistant Staphylococcus aureus infections.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

17 June 2018

Clinical Study of Combination Therapy with Oxacillin and Rifampin for Staphylococcal Infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

17 June 2018

Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

17 June 2018

Rifampin therapy of Staphylococcus epidermidis. Use in infections from indwelling artificial devices

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174860

17 June 2018

Antistaphylococcal Activity of Rifampin with Other Antibiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The emergence of methicillin-resistant Staphylococcus aureus

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of glycopeptide antibiotics on human phagocyte activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Killing of Intraleukocytie Staphylococcus aureus by Rifampin: In-Vitro and In-Vivo Studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/2959197

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.31.7.1002

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39828319&oldid=2091052834"